ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	23/168	167/7206	3.75959170496e-12
ko05168	Herpes simplex infection	21/168	182/7206	1.02199877269e-09
ko05140	Leishmaniasis	14/168	75/7206	1.32930321281e-09
ko05162	Measles	17/168	120/7206	1.8762345103e-09
ko05145	Toxoplasmosis	17/168	126/7206	4.04320688022e-09
ko05150	Staphylococcus aureus infection	10/168	36/7206	5.46888608594e-09
ko05152	Tuberculosis	20/168	187/7206	9.97677047674e-09
ko04060	Cytokine-cytokine receptor interaction	20/168	191/7206	1.43839243091e-08
ko05340	Primary immunodeficiency	9/168	30/7206	1.54373852705e-08
ko04612	Antigen processing and presentation	13/168	77/7206	1.90087468506e-08
ko04621	NOD-like receptor signaling pathway	18/168	157/7206	1.92726193546e-08
ko05321	Inflammatory bowel disease (IBD)	11/168	56/7206	4.78695835604e-08
ko04672	Intestinal immune network for IgA production	9/168	37/7206	1.16661560593e-07
ko05330	Allograft rejection	7/168	24/7206	8.18662461129e-07
ko04659	Th17 cell differentiation	13/168	106/7206	9.15552821034e-07
ko04658	Th1 and Th2 cell differentiation	12/168	96/7206	1.98991795519e-06
ko05320	Autoimmune thyroid disease	7/168	29/7206	3.34576117428e-06
ko04217	Necroptosis	16/168	178/7206	3.41569553579e-06
ko04064	NF-kappa B signaling pathway	11/168	96/7206	1.2655387501e-05
ko04380	Osteoclast differentiation	13/168	134/7206	1.29115657313e-05
ko04610	Complement and coagulation cascades	10/168	79/7206	1.30561385824e-05
ko04650	Natural killer cell mediated cytotoxicity	11/168	97/7206	1.39894520469e-05
ko04620	Toll-like receptor signaling pathway	11/168	100/7206	1.87512045019e-05
ko04145	Phagosome	14/168	162/7206	2.24906721693e-05
ko05310	Asthma	5/168	17/7206	3.19993013325e-05
ko05416	Viral myocarditis	8/168	55/7206	3.53683756069e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	15/168	191/7206	3.54613847733e-05
ko05332	Graft-versus-host disease	5/168	18/7206	4.34754166833e-05
ko05161	Hepatitis B	14/168	173/7206	4.68965568783e-05
ko05323	Rheumatoid arthritis	9/168	89/7206	0.000210971841402
ko05160	Hepatitis C	12/168	153/7206	0.000222496479774
ko04611	Platelet activation	12/168	163/7206	0.000399816992915
ko04622	RIG-I-like receptor signaling pathway	7/168	62/7206	0.000552199941814
ko04660	T cell receptor signaling pathway	10/168	124/7206	0.000600457021425
ko04640	Hematopoietic cell lineage	7/168	64/7206	0.000670826750336
ko04940	Type I diabetes mellitus	5/168	32/7206	0.000784553775966
ko04514	Cell adhesion molecules (CAMs)	10/168	130/7206	0.000869599618725
ko04630	Jak-STAT signaling pathway	10/168	132/7206	0.000978773948753
ko03050	Proteasome	6/168	54/7206	0.00150158812956
ko04623	Cytosolic DNA-sensing pathway	5/168	41/7206	0.0024659568557
ko04670	Leukocyte transendothelial migration	10/168	151/7206	0.00269006680493
ko05144	Malaria	5/168	45/7206	0.00373056036714
ko05133	Pertussis	7/168	87/7206	0.0040354011104
ko04662	B cell receptor signaling pathway	7/168	88/7206	0.00430005893104
ko04062	Chemokine signaling pathway	11/168	201/7206	0.00716826639126
ko04664	Fc epsilon RI signaling pathway	6/168	77/7206	0.00888894466218
ko00120	Primary bile acid biosynthesis	3/168	20/7206	0.0106000393498
ko05142	Chagas disease (American trypanosomiasis)	8/168	130/7206	0.0107992005811
ko05418	Fluid shear stress and atherosclerosis	9/168	173/7206	0.0195490755561
ko04668	TNF signaling pathway	7/168	120/7206	0.0217588992429
ko05322	Systemic lupus erythematosus	8/168	151/7206	0.0245500319522
ko05134	Legionellosis	5/168	74/7206	0.0287446251655
ko05169	Epstein-Barr virus infection	10/168	206/7206	0.0291666250746
ko00590	Arachidonic acid metabolism	4/168	52/7206	0.032430441871
ko05131	Shigellosis	5/168	82/7206	0.0420534355312
ko05166	HTLV-I infection	12/168	292/7206	0.0470746129415